Cargando…

Prevalence of co-morbidity and history of recent infection in patients with neuromuscular disease: A cross-sectional analysis of United Kingdom primary care data

BACKGROUND: People with neuromuscular disease (NMD) experience a broader range of chronic diseases and health symptoms compared to the general population. However, no comprehensive analysis has directly quantified this to our knowledge. METHODS: We used a large UK primary care database (Clinical Pra...

Descripción completa

Detalles Bibliográficos
Autores principales: Carey, Iain M., Nirmalananthan, Niranjanan, Harris, Tess, DeWilde, Stephen, Chaudhry, Umar A. R., Limb, Elizabeth, Cook, Derek G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9977045/
https://www.ncbi.nlm.nih.gov/pubmed/36857388
http://dx.doi.org/10.1371/journal.pone.0282513
_version_ 1784899209666756608
author Carey, Iain M.
Nirmalananthan, Niranjanan
Harris, Tess
DeWilde, Stephen
Chaudhry, Umar A. R.
Limb, Elizabeth
Cook, Derek G.
author_facet Carey, Iain M.
Nirmalananthan, Niranjanan
Harris, Tess
DeWilde, Stephen
Chaudhry, Umar A. R.
Limb, Elizabeth
Cook, Derek G.
author_sort Carey, Iain M.
collection PubMed
description BACKGROUND: People with neuromuscular disease (NMD) experience a broader range of chronic diseases and health symptoms compared to the general population. However, no comprehensive analysis has directly quantified this to our knowledge. METHODS: We used a large UK primary care database (Clinical Practice Research Datalink) to compare the prevalence of chronic diseases and other health conditions, including recent infections between 23,876 patients with NMD ever recorded by 2019 compared to 95,295 age-sex-practice matched patients without NMD. Modified Poisson regression estimated Prevalence Ratios (PR) to summarise the presence of the disease/condition ever (or for infections in 2018) in NMD patients versus non-NMD patients. RESULTS: Patients with NMD had significantly higher rates for 16 of the 18 conditions routinely recorded in the primary care Quality and Outcomes Framework (QOF). Approximately 1-in-10 adults with NMD had ≥4 conditions recorded (PR = 1.39, 95%CI 1.33–1.45). Disparities were more pronounced at younger ages (18–49). For other (non-QOF) health conditions, significantly higher recorded levels were observed for rarer events (pulmonary embolism PR = 1.96 95%CI 1.76–2.18, hip fractures PR = 1.65 95%CI 1.47–1.85) as well as for more common primary care conditions (constipation PR = 1.52 95%CI 1.46–1.57, incontinence PR = 1.52 95%CI 1.44–1.60). The greatest co-morbidity burden was in patients with a myotonic disorder. Approximately 1-in-6 (17.1%) NMD patients had an infection recorded in the preceding year, with the risk of being hospitalised with an infection nearly double (PR = 1.92, 95%CI 1.79–2.07) compared to non-NMD patients. CONCLUSION: The burden of chronic co-morbidity among patients with NMD is extremely high compared to the general population, and they are also more likely to present in primary and secondary care for acute events such as infections.
format Online
Article
Text
id pubmed-9977045
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-99770452023-03-02 Prevalence of co-morbidity and history of recent infection in patients with neuromuscular disease: A cross-sectional analysis of United Kingdom primary care data Carey, Iain M. Nirmalananthan, Niranjanan Harris, Tess DeWilde, Stephen Chaudhry, Umar A. R. Limb, Elizabeth Cook, Derek G. PLoS One Research Article BACKGROUND: People with neuromuscular disease (NMD) experience a broader range of chronic diseases and health symptoms compared to the general population. However, no comprehensive analysis has directly quantified this to our knowledge. METHODS: We used a large UK primary care database (Clinical Practice Research Datalink) to compare the prevalence of chronic diseases and other health conditions, including recent infections between 23,876 patients with NMD ever recorded by 2019 compared to 95,295 age-sex-practice matched patients without NMD. Modified Poisson regression estimated Prevalence Ratios (PR) to summarise the presence of the disease/condition ever (or for infections in 2018) in NMD patients versus non-NMD patients. RESULTS: Patients with NMD had significantly higher rates for 16 of the 18 conditions routinely recorded in the primary care Quality and Outcomes Framework (QOF). Approximately 1-in-10 adults with NMD had ≥4 conditions recorded (PR = 1.39, 95%CI 1.33–1.45). Disparities were more pronounced at younger ages (18–49). For other (non-QOF) health conditions, significantly higher recorded levels were observed for rarer events (pulmonary embolism PR = 1.96 95%CI 1.76–2.18, hip fractures PR = 1.65 95%CI 1.47–1.85) as well as for more common primary care conditions (constipation PR = 1.52 95%CI 1.46–1.57, incontinence PR = 1.52 95%CI 1.44–1.60). The greatest co-morbidity burden was in patients with a myotonic disorder. Approximately 1-in-6 (17.1%) NMD patients had an infection recorded in the preceding year, with the risk of being hospitalised with an infection nearly double (PR = 1.92, 95%CI 1.79–2.07) compared to non-NMD patients. CONCLUSION: The burden of chronic co-morbidity among patients with NMD is extremely high compared to the general population, and they are also more likely to present in primary and secondary care for acute events such as infections. Public Library of Science 2023-03-01 /pmc/articles/PMC9977045/ /pubmed/36857388 http://dx.doi.org/10.1371/journal.pone.0282513 Text en © 2023 Carey et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Carey, Iain M.
Nirmalananthan, Niranjanan
Harris, Tess
DeWilde, Stephen
Chaudhry, Umar A. R.
Limb, Elizabeth
Cook, Derek G.
Prevalence of co-morbidity and history of recent infection in patients with neuromuscular disease: A cross-sectional analysis of United Kingdom primary care data
title Prevalence of co-morbidity and history of recent infection in patients with neuromuscular disease: A cross-sectional analysis of United Kingdom primary care data
title_full Prevalence of co-morbidity and history of recent infection in patients with neuromuscular disease: A cross-sectional analysis of United Kingdom primary care data
title_fullStr Prevalence of co-morbidity and history of recent infection in patients with neuromuscular disease: A cross-sectional analysis of United Kingdom primary care data
title_full_unstemmed Prevalence of co-morbidity and history of recent infection in patients with neuromuscular disease: A cross-sectional analysis of United Kingdom primary care data
title_short Prevalence of co-morbidity and history of recent infection in patients with neuromuscular disease: A cross-sectional analysis of United Kingdom primary care data
title_sort prevalence of co-morbidity and history of recent infection in patients with neuromuscular disease: a cross-sectional analysis of united kingdom primary care data
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9977045/
https://www.ncbi.nlm.nih.gov/pubmed/36857388
http://dx.doi.org/10.1371/journal.pone.0282513
work_keys_str_mv AT careyiainm prevalenceofcomorbidityandhistoryofrecentinfectioninpatientswithneuromusculardiseaseacrosssectionalanalysisofunitedkingdomprimarycaredata
AT nirmalananthanniranjanan prevalenceofcomorbidityandhistoryofrecentinfectioninpatientswithneuromusculardiseaseacrosssectionalanalysisofunitedkingdomprimarycaredata
AT harristess prevalenceofcomorbidityandhistoryofrecentinfectioninpatientswithneuromusculardiseaseacrosssectionalanalysisofunitedkingdomprimarycaredata
AT dewildestephen prevalenceofcomorbidityandhistoryofrecentinfectioninpatientswithneuromusculardiseaseacrosssectionalanalysisofunitedkingdomprimarycaredata
AT chaudhryumarar prevalenceofcomorbidityandhistoryofrecentinfectioninpatientswithneuromusculardiseaseacrosssectionalanalysisofunitedkingdomprimarycaredata
AT limbelizabeth prevalenceofcomorbidityandhistoryofrecentinfectioninpatientswithneuromusculardiseaseacrosssectionalanalysisofunitedkingdomprimarycaredata
AT cookderekg prevalenceofcomorbidityandhistoryofrecentinfectioninpatientswithneuromusculardiseaseacrosssectionalanalysisofunitedkingdomprimarycaredata